BIOCON LIMITED. Financial Ratios
BIOCON · Healthcare · Current price ₹399.95
P/E ratio
168.1x
P/B ratio
2.0x
ROE
1.4%
ROCE
4.0%
Debt / Equity
0.04
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 168.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 1.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.04 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with BIOCON LIMITED.'s latest numbers.
BIOCON LIMITED. profitability
BIOCON LIMITED. generates a return on equity of 1.4% and a return on capital employed of 4.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.04 and a P/E of 168.1x, BIOCON LIMITED. is conservatively financed. Our overall business-quality score for the company is 2.8 / 10.
Understand the ratios
More on BIOCON LIMITED.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.